Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide is a synthetic small molecule belonging to the class of proline derivatives. It has a molecular formula of C13H19N3O6S and a molecular weight of approximately 345.37 g/mol. The compound is listed as an experimental pharmaceutical in chemical databases but does not have any approved medical indications or known clinical use as of now. Its mechanism of action, biological targets, and therapeutic applications are not described in public drug or clinical trial registries[1][2][3][7]. No information on its pharmacological activity or development status for specific diseases is available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide.